496 related articles for article (PubMed ID: 30143957)
41. Vagus nerve stimulation for medically refractory epilepsy; efficacy and cost-benefit analysis.
Boon P; Vonck K; Vandekerckhove T; D'have M; Nieuwenhuis L; Michielsen G; Vanbelleghem H; Goethals I; Caemaert J; Calliauw L; De Reuck J
Acta Neurochir (Wien); 1999; 141(5):447-52; discussion 453. PubMed ID: 10392199
[TBL] [Abstract][Full Text] [Related]
42. Development of a clinical model to predict vagus nerve stimulation response in pediatric patients with drug-resistant epilepsy.
Muthiah N; Mallela AN; Vodovotz L; Sharma N; Akwayena E; Pan E; Welch W; Ibrahim GM; Abel TJ
J Neurosurg Pediatr; 2023 May; 31(5):476-483. PubMed ID: 36805960
[TBL] [Abstract][Full Text] [Related]
43. One-year cost-effectiveness of callosotomy vs vagus nerve stimulation for drug-resistant seizures in Lennox-Gastaut Syndrome: A decision analytic model.
Abel TJ; Remick M; Welch WC; Smith KJ
Epilepsia Open; 2022 Mar; 7(1):124-130. PubMed ID: 34890113
[TBL] [Abstract][Full Text] [Related]
44. [Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy].
Sugiyama I; Fukumura M; Kosugi K; Toda M
Brain Nerve; 2022 Aug; 74(8):985-990. PubMed ID: 35941795
[TBL] [Abstract][Full Text] [Related]
45. Treatment of drug-resistant epilepsy with vagus nerve stimulation -- review of 45 cases.
Bao M; Zhou J; Luan GM
Chin Med J (Engl); 2011 Dec; 124(24):4184-8. PubMed ID: 22340384
[TBL] [Abstract][Full Text] [Related]
46. The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.
Hajtovic S; LoPresti MA; Zhang L; Katlowitz KA; Kizek DJ; Lam S
J Neurosurg Pediatr; 2022 Jun; 29(6):667-680. PubMed ID: 35303699
[TBL] [Abstract][Full Text] [Related]
47. Health Technology Assessment Report on Vagus Nerve Stimulation in Drug-Resistant Epilepsy.
Marras CE; Colicchio G; De Palma L; De Benedictis A; Di Gennaro G; Cavaliere M; Cesaroni E; Consales A; Asioli S; Caulo M; Villani F; Zamponi N
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32847092
[No Abstract] [Full Text] [Related]
48. Generator replacement with cardiac-based VNS device in children with drug-resistant epilepsy: An observational study.
Hadjinicolaou A; Jain P; Arya R; Roth C; Whitney R; Yau I; Greiner HM; Mangano FT; Rutka JT; Go C
Epilepsy Res; 2020 Nov; 167():106431. PubMed ID: 32712541
[TBL] [Abstract][Full Text] [Related]
49. Comparison of healthcare resource utilization in pediatric patients with refractory epilepsy: Vagus nerve stimulation and medical treatment cohorts.
Zhang L; Wu JY; Lam SK
Epilepsy Behav; 2021 Oct; 123():108281. PubMed ID: 34509035
[TBL] [Abstract][Full Text] [Related]
50. Vagus nerve stimulation has a positive effect on mood in patients with refractory epilepsy.
Klinkenberg S; Majoie HJ; van der Heijden MM; Rijkers K; Leenen L; Aldenkamp AP
Clin Neurol Neurosurg; 2012 May; 114(4):336-40. PubMed ID: 22130047
[TBL] [Abstract][Full Text] [Related]
51. Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome.
Katagiri M; Iida K; Kagawa K; Hashizume A; Ishikawa N; Hanaya R; Arita K; Kurisu K
Acta Neurochir (Wien); 2016 May; 158(5):1005-12. PubMed ID: 26979179
[TBL] [Abstract][Full Text] [Related]
52. Estimating Long-Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes.
Révész D; Fröjd V; Rydenhag B; Ben-Menachem E
Neuromodulation; 2018 Dec; 21(8):797-804. PubMed ID: 29608227
[TBL] [Abstract][Full Text] [Related]
53. Clinical and economic burden of breakthrough seizures.
Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of vagus nerve stimulation for drug-resistant epilepsy in children age six and younger.
Muthiah N; Zhang J; Remick M; Welch W; Sogawa Y; Jeong JH; Abel TJ
Epilepsy Behav; 2020 Nov; 112():107373. PubMed ID: 32942207
[TBL] [Abstract][Full Text] [Related]
55. Transcutaneous Vagus Nerve Stimulation (t-VNS) and epilepsy: A systematic review of the literature.
Lampros M; Vlachos N; Zigouris A; Voulgaris S; Alexiou GA
Seizure; 2021 Oct; 91():40-48. PubMed ID: 34090145
[TBL] [Abstract][Full Text] [Related]
56. Retention rate of vagus nerve stimulation for the treatment of drug-resistant epilepsy: A single-centre, retrospective study.
Durez A; Theys T; van Loon J; Van Paesschen W
Epilepsy Res; 2024 Jul; 203():107383. PubMed ID: 38795656
[TBL] [Abstract][Full Text] [Related]
57. Neurological results of the modified treatment of epilepsy by stimulation of the vagus nerve.
Vaiman M; Heyman E; Lotan G
Childs Nerv Syst; 2017 Nov; 33(11):2017-2022. PubMed ID: 28689344
[TBL] [Abstract][Full Text] [Related]
58. Vagus nerve stimulation for drug-resistant epilepsy induced by tuberous sclerosis complex.
Tong X; Wang X; Qin L; Zhou J; Guan Y; Teng P; Wang J; Yang Y; Li T; Luan G
Epilepsy Behav; 2022 Jan; 126():108431. PubMed ID: 34883463
[TBL] [Abstract][Full Text] [Related]
59. Vagus nerve stimulation for conservative therapy-refractive epilepsy and depression.
Möbius H; Welkoborsky HJ
Laryngorhinootologie; 2022 May; 101(S 01):S114-S143. PubMed ID: 35605616
[TBL] [Abstract][Full Text] [Related]
60. Safety of vagus nerve stimulation and responsive neurostimulation used in combination for multifocal and generalized onset epilepsy in pediatric patients.
Beaudreault CP; Spirollari E; Naftchi AF; Sukul V; Das A; Vazquez S; Wolf SM; McGoldrick PE; Muh CR
J Neurosurg Pediatr; 2023 Jun; 31(6):565-573. PubMed ID: 36933267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
